Every international health plan says it covers cancer. Almost none of them are lying. And yet expats still end up paying for their own treatment — because of where modern cancer treatment actually happens.
Treatment moved. Most policies were written for where it used to happen
A generation ago, cancer treatment meant admission. You were hospitalised, you received chemotherapy or radiotherapy as an inpatient, and your insurance paid the hospital.
Today a large share of treatment happens elsewhere:
- Infusions in a day-patient unit — you arrive in the morning, you leave in the afternoon, you are never admitted overnight.
- Oral targeted therapies and hormone therapies taken at home — dispensed by a pharmacy, swallowed in your kitchen, often for years.
- Immunotherapy delivered in outpatient or day-patient settings.
- PET and CT scans for staging and monitoring, performed on an outpatient basis, repeatedly.
Radiotherapy and inpatient admission have not disappeared. But the centre of gravity has shifted, and oral drug regimens in particular can carry an annual cost that rivals a hospital stay — while sitting in an entirely different part of your policy.
Your plan may cover the disease brilliantly and the delivery method not at all.
Three separate boxes your policy is using
Insurers split treatment into inpatient (admitted overnight), day-patient (a hospital bed and a procedure, same day, no overnight stay) and outpatient (no bed at all — consultations, scans, take-home prescriptions).
Most core international plans cover inpatient and day-patient. Outpatient is frequently a separate purchase. So the questions that matter are not "is cancer covered?" but:
- Is my infusion in a day-patient unit treated as day-patient, or as outpatient?
- Are oral anti-cancer drugs dispensed to take home covered — and up to what limit?
- Are outpatient PET and CT scans covered, and is there a separate cap on advanced imaging?
- Are outpatient specialist consultations with my oncologist covered, and how many?
What this looks like in two real 2026 schedules
Cigna Global. The core International Medical Insurance plan covers cancer care, including cancer preventative surgery. But that core plan explicitly does not cover outpatient consultations with specialists, or prescribed drugs and dressings required on an outpatient basis. Those sit in the separately purchased International Outpatient module — where prescribed drugs and dressings are capped at $1,500 on Silver and $3,000 on Gold, paid in full only on Platinum. Advanced medical imaging (MRI, CT, PET) is capped at $10,000 on Silver and $15,000 on Gold, whether inpatient, day-patient or outpatient.
Read that again. A Cigna Silver holder with no outpatient module has cancer cover — and no cover for the oral drugs, the oncologist consultations, or imaging beyond $10,000.
Bupa Global. Cancer treatment is paid in full on every tier, and Bupa places it in the "in-patient and/or out-patient care" section — a materially better structure for modern oncology. But the entry-level Major Medical plan carries no outpatient day-to-day cover at all, its advanced imaging is limited to inpatient and day-patient only, and its prescribed drugs benefit is $1,190 and only where prescribed at the hospital following inpatient or day-patient treatment. Take-home oral therapy does not fit that description.
Same disease. Same treatment. Two very different outcomes, driven entirely by plan architecture.
The five questions to ask before you sign
Put these to your broker or insurer in writing, and keep the reply:
- Is cancer treatment covered on an outpatient basis, not only inpatient and day-patient?
- Are oral anti-cancer drugs dispensed to take home covered — and under which benefit, with what annual limit?
- Is there a separate cap on advanced imaging (PET, CT, MRI), and does it apply across all settings?
- How many outpatient specialist consultations are covered, and is there a money sub-limit inside the outpatient limit?
- If I buy inpatient-only cover to save premium, exactly which parts of a cancer pathway am I giving up?
Question five is the one that changes decisions. Inpatient-only cover is a rational purchase for a healthy 30-year-old worried about catastrophe. It is a poor purchase for anyone whose realistic worst case is eighteen months of outpatient oncology.
The honest summary
The words "cancer care covered" tell you almost nothing. What matters is whether your plan follows the treatment to where the treatment now takes place — the infusion suite, the imaging centre, and your own kitchen table.
Check it before you need it. Once there is a diagnosis, you cannot buy the missing module — it becomes a pre-existing condition, and no insurer will add it retrospectively.
“Ask Mira to check the cancer pathway on your current plan — inpatient, day-patient and outpatient, with the drug and imaging limits made explicit.”
Written and verified by Jean-Marc Herbet — Managing Director, Expat Medicare. Thirty years advising expatriates on international private medical insurance across Asia. Expat Medicare is a licensed IPMI brokerage. This article explains insurance structure and is general information, not personal or medical advice. Treatment decisions are a matter for your treating clinicians. Benefit limits, sub-limits and definitions vary by insurer, plan level, underwriting entity, market and policy year — figures cited are drawn from the insurers' published 2026 schedules. Always refer to the policy documents issued with your quotation.
Want this checked against your own situation?
Get an instant comparison of international plans matched to your age, country and family.
Get your instant quote
